Cargando…
New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer
Chronic inflammation is believed to drive prostate carcinogenesis by producing reactive oxygen species or reactive nitrogen species to induce DNA damage. This effect might subsequently cause epigenetic and genomic alterations, leading to malignant transformation. Although established therapeutic adv...
Autores principales: | Lin, Mingen, Sun, Xue, Lv, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199166/ https://www.ncbi.nlm.nih.gov/pubmed/37215386 http://dx.doi.org/10.1016/j.omto.2023.04.007 |
Ejemplares similares
-
Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma
por: Lin, Mingen, et al.
Publicado: (2023) -
Combined targeted therapy and immunotherapy for cancer treatment
por: Guo, Cheng-Xiang, et al.
Publicado: (2021) -
New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
por: Godbole, Abhijit M., et al.
Publicado: (2011) -
AB085. Immune therapy: new option for prostate cancer
por: Wang, Wei, et al.
Publicado: (2015) -
Combination Immunotherapy in Prostate Cancer
por: Baxevanis, Constantin N., et al.
Publicado: (2022)